Yazhou Yao

VTE Risk Profiles and Prophylaxis in Medical and Surgical Inpatients

Zhenguo Zhai, Quancheng Kan, Weimin Li et al. · CHEST Journal · 2018 · 97 citations · Full text

Medicine, Internal Medicine, Clinical Epidemiology +16

A multicenter, randomized phase III trial of hetrombopag: a novel thrombopoietin receptor agonist for the treatment of immune thrombocytopenia

Heng Mei, Xiaofan Liu, Yan Li et al. · Journal of Hematology & Oncology · 2021 · 72 citations · Full text

Medicine, Hematology, Pharmacology +12

Oxymatrine triggers apoptosis by regulating Bcl-2 family proteins and activating caspase-3/caspase-9 pathway in human leukemia HL-60 cells

Jun Liu, Yazhou Yao, Huifang Ding et al. · Tumor Biology · 2014 · 45 citations

Life Sciences, Oncology, Pharmacology +17

An effective and chemotherapy-free strategy of all-trans retinoic acid and arsenic trioxide for acute promyelocytic leukemia in all risk groups (APL15 trial)

Huaiyu Wang, Sha Gong, Guohui Li et al. · Blood Cancer Journal · 2022 · 39 citations · Full text

Medicine, Hematology, Oncology +6

Dose tapering to withdrawal stage and long‐term efficacy and safety of hetrombopag for the treatment of immune thrombocytopenia: Results from an open‐label extension study

Heng Mei, Xiaofan Liu, Yan Li et al. · Journal of Thrombosis and Haemostasis · 2021 · 14 citations · Full text

Medicine, Hematology, Pharmacology +6